Method for detection of melanoma
US7297480B2 · kind B2 · utility
35Cited by
8References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2002 |
| Grant date | Nov 20, 2007 |
| Priority date | — |
| Expiry date | Oct 15, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/912
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides non-invasive methods for detecting, monitoring, staging, and diagnosing malignant melanoma in a skin sample of a subject. The methods include analyzing expression in skin sample of one or more melanoma skin markers. The melanoma skin markers include IL-1 RI, endothelin-2, ephrin-A5, IGF Binding Protein 7, HLA-A0202 heavy chain, Activin A (βA subunit), TNF RII, SPC4, and CNTF Rα. The skin sample can include nucleic acids, and can be a human skin sample from a lesion suspected of being melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.